Halper Sadeh LLC is investigating whether officers and directors of ASP Isotopes Inc. breached their fiduciary duties to shareholders. Long-term shareholders may seek corporate governance reforms, financial incentives, or other relief. The law firm offers free consultations and works on a contingent fee basis, emphasizing the importance of timely action to protect shareholder rights. This could lead to improved company oversight and potential financial recoveries for investors.
The story concerns ASP Isotopes Inc. insiders and fiduciary duties. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 29, 2026 05:11 WIB: out of 38 priced US stocks, 7 rose and 31 fell. Notable movers include Johnson Controls International PLC (JCI) with a price of USD 150.33 and a 1-day change of +3.42%, LyondellBasell Industries NV (LYB) at USD 58.15 with a 1-day change of -3.39% and 100% sell order activity, and CF Industries Holdings, Inc. (CF) at USD 114.75 with a 1-day change of -3.11% and 99% buy order activity on Pluang.
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
